Suivre
Rene maltais
Rene maltais
Adresse e-mail validée de crchul.ulaval.ca
Titre
Citée par
Citée par
Année
Steroid sulfatase inhibitors: a review covering the promising 2000–2010 decade
R Maltais, D Poirier
Steroids 76 (10-11), 929-948, 2011
902011
Steroid sulfatase inhibitors
D Poirier, LC Ciobanu, R Maltais
Expert Opinion on Therapeutic Patents 9 (8), 1083-1099, 1999
831999
Synthesis and optimization of a new family of type 3 17β-hydroxysteroid dehydrogenase inhibitors by parallel liquid-phase chemistry
R Maltais, V Luu-The, D Poirier
Journal of medicinal chemistry 45 (3), 640-653, 2002
782002
Solid-phase synthesis of hydroxysteroid derivatives using the diethylsilyloxy linker
R Maltais, MR Tremblay, D Poirier
Journal of Combinatorial Chemistry 2 (6), 604-614, 2000
612000
Impact of estradiol structural modifications (18-methyl and/or 17-hydroxy inversion of configuration) on the in vitro and in vivo estrogenic activity
D Ayan, J Roy, R Maltais, D Poirier
The Journal of steroid biochemistry and molecular biology 127 (3-5), 324-330, 2011
602011
A new nonestrogenic steroidal inhibitor of 17β-hydroxysteroid dehydrogenase type I blocks the estrogen-dependent breast cancer tumor growth induced by estrone
D Ayan, R Maltais, J Roy, D Poirier
Molecular cancer therapeutics 11 (10), 2096-2104, 2012
592012
Steroids and combinatorial chemistry
R Maltais, MR Tremblay, LC Ciobanu, D Poirier
Journal of combinatorial chemistry 6 (4), 443-456, 2004
562004
Discovery of a Non-Estrogenic Irreversible Inhibitor of 17β-Hydroxysteroid Dehydrogenase Type 1 from 3-Substituted-16β-(m-carbamoylbenzyl)-estradiol Derivatives
R Maltais, D Ayan, A Trottier, X Barbeau, P Lagüe, JE Bouchard, ...
Journal of medicinal chemistry 57 (1), 204-222, 2014
432014
Identification of a 17β‐Hydroxysteroid Dehydrogenase Type 10 Steroidal Inhibitor: A Tool to Investigate the Role of Type 10 in Alzheimer’s Disease and Prostate Cancer
D Ayan, R Maltais, D Poirier
ChemMedChem 7 (7), 1181-1184, 2012
372012
Chemical synthesis, cytotoxicity, selectivity and bioavailability of 5α-androstane-3α, 17β-diol derivatives
D Ayan, R Maltais, A Hospital, D Poirier
Bioorganic & medicinal chemistry 22 (21), 5847-5859, 2014
362014
Development of 3-substituted-androsterone derivatives as potent inhibitors of 17β-hydroxysteroid dehydrogenase type 3
R Maltais, MA Fournier, D Poirier
Bioorganic & medicinal chemistry 19 (15), 4652-4668, 2011
352011
Parallel solid-phase synthesis of 3β-peptido-3α-hydroxy-5α-androstan-17-one derivatives for inhibition of type 3 17β-hydroxysteroid dehydrogenase
R Maltais, V Luu-The, D Poirier
Bioorganic & medicinal chemistry 9 (12), 3101-3111, 2001
35*2001
Targeting cytochrome P450 (CYP) 1B1 enzyme with four series of A-ring substituted estrane derivatives: design, synthesis, inhibitory activity, and selectivity
R Dutour, J Roy, F Cortés-Benítez, R Maltais, D Poirier
Journal of Medicinal Chemistry 61 (20), 9229-9245, 2018
312018
A novel aminosteroid of the 5α-androstane-3α, 17β-diol family induces cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells
H Jegham, J Roy, R Maltais, S Desnoyers, D Poirier
Investigational new drugs 30, 176-185, 2012
312012
Libraries of 2β-(N-substituted piperazino)-5α-androstane-3α, 17β-diols: chemical synthesis and cytotoxic effects on human leukemia HL-60 cells and on normal …
J Roy, R Maltais, H Jegham, D Poirier
Molecular diversity 15, 317-339, 2011
312011
Discovery of a sulfamate-based steroid sulfatase inhibitor with intrinsic selective estrogen receptor modulator properties
C Ouellet, R Maltais, É Ouellet, X Barbeau, P Lagüe, D Poirier
European Journal of Medicinal Chemistry 119, 169-182, 2016
302016
A solution-phase combinatorial parallel synthesis of 3β-amido-3α-hydroxy-5α-androstane-17-ones
D Poirier
Tetrahedron letters 39 (24), 4151-4154, 1998
271998
Design of a Mestranol 2‐N‐Piperazino‐Substituted Derivative Showing Potent and Selective in vitro and in vivo Activities in MCF‐7 Breast Cancer Models
M Perreault, R Maltais, J Roy, R Dutour, D Poirier
ChemMedChem 12 (2), 177-182, 2017
262017
Chemical synthesis, NMR analysis and evaluation on a cancer xenograft model (HL-60) of the aminosteroid derivative RM-133
R Maltais, A Hospital, A Delhomme, J Roy, D Poirier
Steroids 82, 68-76, 2014
262014
The sulfamate functional group as a new anchor for solid-phase organic synthesis
LC Ciobanu, R Maltais, D Poirier
Organic Letters 2 (4), 445-448, 2000
262000
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20